| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.42 | 2e-09 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0004 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.001 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.006 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |